Page last updated: 2024-09-02

tesmilifene and Pleural Effusion, Malignant

tesmilifene has been researched along with Pleural Effusion, Malignant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, T; Eisen, A; Liu, JC; Pritchard, KI; Zacksenhaus, E	1

Other Studies

1 other study(ies) available for tesmilifene and Pleural Effusion, Malignant

Article	Year
Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-01, Volume: 15, Issue:1 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; CD24 Antigen; Cell Adhesion; Cell Cycle; Cell Death; Cell Line, Tumor; Doxorubicin; Humans; Hyaluronan Receptors; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Phenyl Ethers; Pleural Effusion, Malignant	2009

Article

Year

Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-01, Volume: 15, Issue:1

Topics: Animals; Antineoplastic Agents; Breast Neoplasms; CD24 Antigen; Cell Adhesion; Cell Cycle; Cell Death; Cell Line, Tumor; Doxorubicin; Humans; Hyaluronan Receptors; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Phenyl Ethers; Pleural Effusion, Malignant

2009